AlzChem Group AG

ACT.DE

Chemicals - Specialty · Basic Materials

Price

€160.00

+1.90 (+1.20%)

Market Cap

€1.62B

Exchange

Frankfurt Stock Exchange

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Good

Growth

Strong

Cash Flow

Strong

Stability

Exceptional

Valuation

Strong

Dividends

Weak

Track this stock — start free trial

Winston Score History

The full picture

AlzChem Group AG is a German specialty chemicals company that makes a range of nitrogen-based chemical products. Its most important product is creatine, a supplement used by athletes and in animal feed, where AlzChem is one of the largest producers in the world. The company also makes chemicals used in agriculture, construction, and industrial processes.

AlzChem earns money by selling these chemicals to manufacturers, food and supplement companies, and agricultural businesses, primarily across Europe but also globally. Its main production site is in Trostberg, Bavaria, Germany, giving it a tightly integrated supply chain that is difficult for competitors to replicate quickly. The company's biggest growth opportunity is rising global demand for creatine, both in human nutrition and animal feed, but its main risk is that it relies heavily on a small number of key products and a single large production location, making it vulnerable to supply disruptions or shifts in raw material costs.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+5.7% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

€11M/ year

→ Flat (-1% vs prior year)

1.9% of revenue

Below sector average (3%)

Steady R&D investment year-over-year

Insider Activity

52.3%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€66M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

AlzChem Group AG is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

−0.7% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 10.2M (2021) → 10.1M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

31.5%

Modest — 31.5% gross margin

Profit after running costs

Operating Margin

15.9%

Healthy — 15.9% operating margin

Return on the money invested

ROCE

24.5%

Exceptional — 24.5% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+4.5%

Slow sales growth (+4.5% YoY)

Profit growth

EPS YoY

+17.1%

Earnings growing fast (+17.1% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

7/8 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

172%

Turns 172% of profit into real cash

Spare cash per sale

FCF Margin

3.2%

Thin free cash flow (3.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.33

Conservative — low debt load (0.33)

Covers its interest

Interest Cover

42.04x

Comfortably covers interest (42.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

23.9x

Growth-priced — P/E 23.9

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year

P/E vs Forward

+8.6

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (23.9 → 15.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

1.31%

Small dividend — 1.31% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial